![]() |
|
|
|||||||
|
|
LinkBack | Thread Tools | Display Modes |
|
|||
|
Having obtained Health Canada approval, Australian Department of Health approval, and an EU CE mark this year for its Raman spectroscopy-based skin cancer diagnostic device, Canadian biotech firm Verisante has begun pursuing US Food and Drug Administration approval.
|
| Thread Tools | |
| Display Modes | |
|
|